Company Filing History:
Years Active: 2020
Title: Shani Attias: Innovator in Pulmonary Delivery Systems
Introduction
Shani Attias is an accomplished inventor based in Kiryat Motzkin, Israel. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of controlled release systems for pulmonary delivery.
Latest Patents
Attias holds a patent for a controlled release system designed for the pulmonary delivery of surfactant protein D (SPD). This innovative system incorporates SPD and a suitable carrier, such as polylactic-co-glycolic acid (PLGA). The system can be formulated as a nanoparticle, enhancing its effectiveness. The pharmaceutical composition includes this system along with a pharmaceutically acceptable carrier. The methods of treatment involve administering the composition to subjects with decreased levels of SPD, addressing various diseases and conditions.
Career Highlights
Throughout his career, Shani Attias has worked with notable organizations, including B.G. Negev Technologies and Applications Ltd. and Children's Hospital Medical Center. His work has focused on advancing medical technologies that improve patient outcomes.
Collaborations
Attias has collaborated with professionals such as Joseph Kost and Tamar Traitel, who have contributed to his research and development efforts.
Conclusion
Shani Attias is a pioneering inventor whose work in controlled release systems for pulmonary delivery has the potential to transform treatment options for patients. His innovative approach and collaborations highlight the importance of teamwork in advancing medical technology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.